Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy

Area of Science:

• Oncology
• Nanotechnology
• Drug Delivery

Background:

• Cancer poses a significant global health challenge, with conventional chemotherapy exhibiting limited tumor specificity and causing systemic toxicity.
• Nanocarrier systems have emerged as a promising strategy to overcome these limitations by enabling targeted drug delivery.
• These systems offer improved bioavailability, enhanced retention, and reduced harm to healthy tissues.

Purpose of the Study:

• To review various nanocarrier-based drug delivery systems for cancer management.
• To emphasize the applications and advancements of mesoporous silica nanoparticles (MSNs) in targeted cancer therapy.

Main Methods:

• Review of existing literature on nanocarrier systems in cancer treatment.
• Focus on nanocarrier types including polymeric micelles, liposomes, dendrimers, carbon nanotubes, gold nanoparticles, MSNs, metal-organic frameworks, and quantum dots.

Main Results:

• Nanocarriers demonstrate enhanced specificity for tumor cells, enabling precise drug delivery.
• Various nanocarrier formulations are in clinical trials, showing potential for improved cancer treatment efficacy.
• Mesoporous silica nanoparticles (MSNs) represent a significant advancement in targeted drug delivery systems.

Conclusions:

• Nanocarrier systems, particularly MSNs, offer a promising approach for targeted and effective cancer therapy.
• These advanced systems have the potential to revolutionize cancer treatment by minimizing side effects and maximizing therapeutic outcomes.
• Continued research and development in nanocarrier technology are crucial for advancing cancer management strategies.